111 related articles for article (PubMed ID: 34592197)
21. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
22. Coexpression network analysis linked H2AFJ to chemoradiation resistance in colorectal cancer.
Wang X; Ghareeb WM; Lu X; Huang Y; Huang S; Chi P
J Cell Biochem; 2019 Jun; 120(6):10351-10362. PubMed ID: 30565747
[TBL] [Abstract][Full Text] [Related]
23. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer.
Ten Hoorn S; Waasdorp C; van Oijen MGH; Damhofer H; Trinh A; Zhao L; Smits LJH; Bootsma S; van Pelt GW; Mesker WE; Mol L; Goey KKH; Koopman M; Medema JP; Tuynman JB; Zlobec I; Punt CJA; Vermeulen L; Bijlsma MF
BMC Cancer; 2022 Apr; 22(1):394. PubMed ID: 35413826
[TBL] [Abstract][Full Text] [Related]
24. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
25. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
Yuan D; Li K; Zhu K; Yan R; Dang C
Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
[TBL] [Abstract][Full Text] [Related]
26. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
28. Identification of lnc RNAs Related to Prognosis of Patients With Colorectal Cancer.
Sun Y; Peng P; He L; Gao X
Technol Cancer Res Treat; 2020; 19():1533033820962120. PubMed ID: 33111631
[TBL] [Abstract][Full Text] [Related]
29. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
Huang Z; Yang Q; Huang Z
Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
[TBL] [Abstract][Full Text] [Related]
30. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
Li DJ; Feng ZC; Li XR; Hu G
World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
[TBL] [Abstract][Full Text] [Related]
31. Integrated pan-cancer of AURKA expression and drug sensitivity analysis reveals increased expression of AURKA is responsible for drug resistance.
Miralaei N; Majd A; Ghaedi K; Peymani M; Safaei M
Cancer Med; 2021 Sep; 10(18):6428-6441. PubMed ID: 34337875
[TBL] [Abstract][Full Text] [Related]
32. CK1α overexpression correlates with poor survival in colorectal cancer.
Richter J; Kretz AL; Lemke J; Fauler M; Werner JU; Paschke S; Leithäuser F; Henne-Bruns D; Hillenbrand A; Knippschild U
BMC Cancer; 2018 Feb; 18(1):140. PubMed ID: 29409464
[TBL] [Abstract][Full Text] [Related]
33. The Long Noncoding RNA, LINC01555, Promotes Invasion and Metastasis of Colorectal Cancer by Activating the Neuropeptide, Neuromedin U.
Wang X; Chen X; Zhou H; Qian Y; Han N; Tian X; Pan L; Li Y
Med Sci Monit; 2019 May; 25():4014-4024. PubMed ID: 31144675
[TBL] [Abstract][Full Text] [Related]
34. Qualitative Ras pathway signature for cetuximab therapy reveals resistant mechanism in colorectal cancer.
Song K; Lu H; Jin L; Wang K; Guo W; Zheng H; Li K; He C; You T; Fu Y; Yang J; Zhao W; Guo Z
FEBS J; 2020 Dec; 287(23):5236-5248. PubMed ID: 32216031
[TBL] [Abstract][Full Text] [Related]
35. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
36. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
37. Expression of NOX Family Genes and Their Clinical Significance in Colorectal Cancer.
Cho SY; Kim JS; Eun HS; Kang SH; Lee ES; Kim SH; Sung JK; Lee BS; Jeong HY; Moon HS
Dig Dis Sci; 2018 Sep; 63(9):2332-2340. PubMed ID: 29781053
[TBL] [Abstract][Full Text] [Related]
38. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of SNX1 predicts poor prognosis and contributes to drug resistance in colorectal cancer.
Bian Z; Feng Y; Xue Y; Hu Y; Wang Q; Zhou L; Liu Z; Zhang J; Yin Y; Gu B; Huang Z
Tumour Biol; 2016 May; 37(5):6619-25. PubMed ID: 26643894
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.
Gharib E; Nasrinasrabadi P; Zali MR
PLoS One; 2020; 15(3):e0229864. PubMed ID: 32155177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
